The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice-Reference-Cited by-同舟云学术

The GRP78-PERK axis contributes to memory and synaptic impairments in Huntington's disease R6/1 mice

Published:2023-08 Issue: Volume:184 Page:106225
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Espina Marc,Di Franco Nadia,Brañas-Navarro Martina,Navarro Irene Rodriguez,Brito Veronica,Lopez-Molina Laura,Costas-Insua Carlos,Guzmán Manuel,Ginés Silvia

Funder

Ministerio de Universidades

Gobierno de Espana Ministerio de Ciencia e Innovacion

Federación Española de Enfermedades Raras

Instituto de Salud Carlos III

Ministerio de Ciencia e Innovación

Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas

Publisher

Elsevier BV

Subject

Neurology

Reference78 articles.

1. Protein aggregation diseases: pathogenicity and therapeutic perspectives;Aguzzi;Nat. Rev. Drug Discov.,2010

2. Prostaglandin E2 EP1 receptor antagonist improves motor deficits and rescues memory decline in R6/1 mouse model of Huntington’s disease;Anglada-Huguet;Mol. Neurobiol.,2014

3. Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro- 1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK);Axten;J. Med. Chem.,2012

4. Huntingtin aggregation and toxicity in Huntington’s disease;Bates;Lancet,2003

5. Hippocampal dysfunction defines disease onset in Huntington’s disease;Begeti;J. Neurol. Neurosurg. Psychiatry,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoplasmic reticulum stress and therapeutic strategies in metabolic, neurodegenerative diseases and cancer;Molecular Medicine;2024-03-20

2. Mild cognitive impairment in Huntington’s disease: challenges and outlooks;Journal of Neural Transmission;2024-01-24